Evogene Ltd.

Evogene Ltd. operates as a computational biology company, utilizing its Computational Predictive Biology (CPB) platform to discover and develop products in agriculture, human health, and industrial applications. The company focuses on developing seed traits, ag-chemical products, and ag-biological products for various crops, as well as human microbiome-based therapeutics for immuno-oncology, GI related disorders, and antimicrobial resistance organisms. Additionally, it develops enhanced castor bean seeds for industrial uses and provides medical cannabis products. Evogene generates revenue through strategic collaborations and licensing agreements with agricultural companies, including BASF SE, Corteva, and Bayer, and through its subsidiary, Canonic Ltd., for the development of medical cannabis products.

Products

• Seed traits

• Ag-chemical products

• Ag-biological products

• Human microbiome-based therapeutics

• Enhanced castor bean seeds

• Medical cannabis products